🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 12 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 02/03/2015 | 34,60 | 39,87 | 34,60 | 39,66 | +15,45% | 15,22% | 1.919.593 |
| 27/02/2015 | 34,78 | 34,81 | 34,26 | 34,35 | -1,34% | 1,58% | 360.835 |
| 26/02/2015 | 35,43 | 35,52 | 34,32 | 34,82 | -1,53% | 3,38% | 935.992 |
| 25/02/2015 | 34,68 | 35,60 | 34,32 | 35,36 | +1,76% | 3,67% | 411.009 |
| 24/02/2015 | 35,55 | 35,55 | 34,37 | 34,75 | -1,88% | 3,33% | 452.527 |
| 23/02/2015 | 35,92 | 36,61 | 35,27 | 35,42 | -1,32% | 3,73% | 389.208 |
| 20/02/2015 | 36,72 | 36,72 | 35,75 | 35,90 | -1,98% | 2,65% | 419.505 |
| 19/02/2015 | 35,86 | 36,68 | 35,56 | 36,62 | +1,57% | 3,13% | 362.278 |
| 18/02/2015 | 35,68 | 36,06 | 35,15 | 36,05 | +1,07% | 2,57% | 328.615 |
| 17/02/2015 | 34,80 | 35,80 | 34,57 | 35,67 | +2,27% | 3,53% | 331.981 |
| 13/02/2015 | 35,30 | 35,36 | 34,07 | 34,88 | -0,62% | 3,66% | 339.996 |
| 12/02/2015 | 35,55 | 35,61 | 34,54 | 35,10 | -0,53% | 3,02% | 304.249 |
| 11/02/2015 | 35,15 | 36,34 | 34,95 | 35,28 | +0,53% | 3,94% | 280.685 |
| 10/02/2015 | 34,19 | 35,40 | 33,39 | 35,10 | +3,13% | 5,88% | 599.843 |
| 09/02/2015 | 32,88 | 34,88 | 30,97 | 34,03 | -0,80% | 11,90% | 1.066.155 |
| 06/02/2015 | 35,12 | 35,12 | 34,01 | 34,30 | -1,87% | 3,18% | 365.003 |
| 05/02/2015 | 33,87 | 35,29 | 33,52 | 34,96 | +3,97% | 5,23% | 380.392 |
| 04/02/2015 | 33,55 | 34,16 | 32,28 | 33,62 | -0,70% | 5,60% | 380.232 |
| 03/02/2015 | 34,72 | 35,65 | 33,23 | 33,86 | -1,76% | 6,97% | 469.358 |
| 02/02/2015 | 35,72 | 36,02 | 33,87 | 34,47 | -2,93% | 6,03% | 334.867 |
| 30/01/2015 | 35,51 | 36,59 | 34,52 | 35,51 | -0,19% | 5,85% | 509.914 |
| 29/01/2015 | 36,03 | 36,13 | 35,06 | 35,58 | -0,68% | 2,98% | 297.517 |
| 28/01/2015 | 37,09 | 37,42 | 35,62 | 35,82 | -1,95% | 4,84% | 397.544 |
| 27/01/2015 | 34,75 | 37,42 | 34,75 | 36,53 | +3,54% | 7,68% | 678.229 |
| 26/01/2015 | 33,99 | 35,34 | 33,86 | 35,28 | +3,46% | 4,35% | 372.858 |
| 23/01/2015 | 34,93 | 35,02 | 33,77 | 34,10 | -2,08% | 3,57% | 381.033 |
| 22/01/2015 | 34,31 | 34,91 | 33,12 | 34,83 | +1,95% | 5,22% | 395.140 |
| 21/01/2015 | 34,13 | 34,70 | 33,25 | 34,16 | +0,05% | 4,24% | 555.279 |
| 20/01/2015 | 34,09 | 34,55 | 33,27 | 34,14 | +0,64% | 3,77% | 352.339 |
| 16/01/2015 | 32,05 | 33,97 | 32,05 | 33,92 | +5,43% | 5,99% | 237.244 |